+948.4%
MRNA vs VALE
+33.7%
+914.7%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | VALE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -3.5% | +1.3% | -1.5% |
| 7D | -12.7% | -15.4% | +2.7% | -10.0% |
| 30D | -20.7% | -25.3% | +4.6% | -16.3% |
| 3M | +46.3% | -33.3% | +79.6% | +57.3% |
| 6M | +305.2% | -40.3% | +345.5% | +342.1% |
| YTD | +561.2% | -25.1% | +586.3% | +601.0% |
| 1Y | +772.1% | -13.8% | +785.9% | +807.9% |
| 3Y | +147.0% | -20.5% | +167.4% | +155.4% |
| 5Y | -26.1% | +25.6% | -51.6% | -25.5% |
| All | +948.4% | +33.7% | +914.7% | +930.7% |
Cumulative growth
Daily Returns
Daily percentage return beside VALE.
Daily Out/Under-Performance
Portfolio return minus VALE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VALE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded VALE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling